Skip to main content
PMC home page
Clinical and Diagnostic Laboratory Immunology logoLink to Clinical and Diagnostic Laboratory Immunology
. 1997 Jul;4(4):423–428. doi: 10.1128/cdli.4.4.423-428.1997

Expression, characterization, and immunoreactivities of a soluble hepatitis E virus putative capsid protein species expressed in insect cells.

Y Zhang 1, P McAtee 1, P O Yarbough 1, A W Tam 1, T Fuerst 1
PMCID: PMC170544  PMID: 9220158

Abstract

The hepatitis E virus (HEV) open reading frame-2 (ORF-2) is predicted to encode a 71-kDa putative capsid protein involved in virus particle formation. When insect Spodoptera frugiperda (Sf9) cells were infected with a recombinant baculovirus containing the entire ORF-2 sequence, two types of recombinant proteins were produced; an insoluble protein of 73 kDa and a soluble protein of 62 kDa. The 62-kDa species was shown to be a proteolytic cleavage product of the 73-kDa protein. N-terminal sequence analysis of the 62-kDa protein indicated that it lacked the first 111 amino acids that are present in the full-length 73-kDa protein. A soluble 62-kDa protein was produced without the proteolytic processing by inserting the coding sequence of amino acids 112 to 660 of ORF-2 in a baculovirus expression vector and using the corresponding virus to infect Sf9 cells. The two recombinant 62-kDa proteins made by different mechanisms displayed immunoreactivities very compatible to each other. The 62-kDa proteins obtained by both proteolytic processing and reengineering demonstrated much higher sensitivities in detecting anti-HEV antibodies in human sera than the antigens made from bacteria, as measured by enzyme-linked immunosorbent assay. The data suggest that the soluble 62-kDa protein made from insect cells contains additional epitopes not present in recombinant proteins made from bacteria. Therefore, the 62-kDa protein may be useful for HEV diagnostic improvement and vaccine development. The reengineered construct allows for the consistent large-scale production of the soluble 62-kDa protein without proteolytic processing.

Full Text

The Full Text of this article is available as a PDF (468.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allan J. S., Coligan J. E., Barin F., McLane M. F., Sodroski J. G., Rosen C. A., Haseltine W. A., Lee T. H., Essex M. Major glycoprotein antigens that induce antibodies in AIDS patients are encoded by HTLV-III. Science. 1985 May 31;228(4703):1091–1094. doi: 10.1126/science.2986290. [DOI] [PubMed] [Google Scholar]
  2. Aye T. T., Uchida T., Ma X. Z., Iida F., Shikata T., Zhuang H., Win K. M. Complete nucleotide sequence of a hepatitis E virus isolated from the Xinjiang epidemic (1986-1988) of China. Nucleic Acids Res. 1992 Jul 11;20(13):3512–3512. doi: 10.1093/nar/20.13.3512. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bradley D. W., Krawczynski K., Cook E. H., Jr, McCaustland K. A., Humphrey C. D., Spelbring J. E., Myint H., Maynard J. E. Enterically transmitted non-A, non-B hepatitis: serial passage of disease in cynomolgus macaques and tamarins and recovery of disease-associated 27- to 34-nm viruslike particles. Proc Natl Acad Sci U S A. 1987 Sep;84(17):6277–6281. doi: 10.1073/pnas.84.17.6277. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bradley D., Andjaparidze A., Cook E. H., Jr, McCaustland K., Balayan M., Stetler H., Velazquez O., Robertson B., Humphrey C., Kane M. Aetiological agent of enterically transmitted non-A, non-B hepatitis. J Gen Virol. 1988 Mar;69(Pt 3):731–738. doi: 10.1099/0022-1317-69-3-731. [DOI] [PubMed] [Google Scholar]
  5. Coursaget P., Buisson Y., Depril N., le Cann P., Chabaud M., Molinié C., Roue R. Mapping of linear B cell epitopes on open reading frames 2- and 3-encoded proteins of hepatitis E virus using synthetic peptides. FEMS Microbiol Lett. 1993 May 15;109(2-3):251–255. doi: 10.1111/j.1574-6968.1993.tb06176.x. [DOI] [PubMed] [Google Scholar]
  6. Dawson G. J., Chau K. H., Cabal C. M., Yarbough P. O., Reyes G. R., Mushahwar I. K. Solid-phase enzyme-linked immunosorbent assay for hepatitis E virus IgG and IgM antibodies utilizing recombinant antigens and synthetic peptides. J Virol Methods. 1992 Jul;38(1):175–186. doi: 10.1016/0166-0934(92)90180-l. [DOI] [PubMed] [Google Scholar]
  7. Favorov M. O., Fields H. A., Purdy M. A., Yashina T. L., Aleksandrov A. G., Alter M. J., Yarasheva D. M., Bradley D. W., Margolis H. S. Serologic identification of hepatitis E virus infections in epidemic and endemic settings. J Med Virol. 1992 Apr;36(4):246–250. doi: 10.1002/jmv.1890360403. [DOI] [PubMed] [Google Scholar]
  8. Fry K. E., Tam A. W., Smith M. M., Kim J. P., Luk K. C., Young L. M., Piatak M., Feldman R. A., Yun K. Y., Purdy M. A. Hepatitis E virus (HEV): strain variation in the nonstructural gene region encoding consensus motifs for an RNA-dependent RNA polymerase and an ATP/GTP binding site. Virus Genes. 1992 Apr;6(2):173–185. doi: 10.1007/BF01703066. [DOI] [PubMed] [Google Scholar]
  9. He J., Tam A. W., Yarbough P. O., Reyes G. R., Carl M. Expression and diagnostic utility of hepatitis E virus putative structural proteins expressed in insect cells. J Clin Microbiol. 1993 Aug;31(8):2167–2173. doi: 10.1128/jcm.31.8.2167-2173.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Huang C. C., Nguyen D., Fernandez J., Yun K. Y., Fry K. E., Bradley D. W., Tam A. W., Reyes G. R. Molecular cloning and sequencing of the Mexico isolate of hepatitis E virus (HEV). Virology. 1992 Dec;191(2):550–558. doi: 10.1016/0042-6822(92)90230-m. [DOI] [PubMed] [Google Scholar]
  11. Jiang X., Wang M., Graham D. Y., Estes M. K. Expression, self-assembly, and antigenicity of the Norwalk virus capsid protein. J Virol. 1992 Nov;66(11):6527–6532. doi: 10.1128/jvi.66.11.6527-6532.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Khudyakov YuE, Favorov M. O., Jue D. L., Hine T. K., Fields H. A. Immunodominant antigenic regions in a structural protein of the hepatitis E virus. Virology. 1994 Jan;198(1):390–393. doi: 10.1006/viro.1994.1048. [DOI] [PubMed] [Google Scholar]
  13. Khudyakov Y. E., Khudyakova N. S., Fields H. A., Jue D., Starling C., Favorov M. O., Krawczynski K., Polish L., Mast E., Margolis H. Epitope mapping in proteins of hepatitis E virus. Virology. 1993 May;194(1):89–96. doi: 10.1006/viro.1993.1238. [DOI] [PubMed] [Google Scholar]
  14. Kirnbauer R., Taub J., Greenstone H., Roden R., Dürst M., Gissmann L., Lowy D. R., Schiller J. T. Efficient self-assembly of human papillomavirus type 16 L1 and L1-L2 into virus-like particles. J Virol. 1993 Dec;67(12):6929–6936. doi: 10.1128/jvi.67.12.6929-6936.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Koonin E. V., Gorbalenya A. E., Purdy M. A., Rozanov M. N., Reyes G. R., Bradley D. W. Computer-assisted assignment of functional domains in the nonstructural polyprotein of hepatitis E virus: delineation of an additional group of positive-strand RNA plant and animal viruses. Proc Natl Acad Sci U S A. 1992 Sep 1;89(17):8259–8263. doi: 10.1073/pnas.89.17.8259. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Labbé M., Charpilienne A., Crawford S. E., Estes M. K., Cohen J. Expression of rotavirus VP2 produces empty corelike particles. J Virol. 1991 Jun;65(6):2946–2952. doi: 10.1128/jvi.65.6.2946-2952.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Longer C. F., Denny S. L., Caudill J. D., Miele T. A., Asher L. V., Myint K. S., Huang C. C., Engler W. F., LeDuc J. W., Binn L. N. Experimental hepatitis E: pathogenesis in cynomolgus macaques (Macaca fascicularis). J Infect Dis. 1993 Sep;168(3):602–609. doi: 10.1093/infdis/168.3.602. [DOI] [PubMed] [Google Scholar]
  18. McAtee C. P., Zhang Y., Yarbough P. O., Bird T., Fuerst T. R. Purification of a soluble hepatitis E open reading frame 2-derived protein with unique antigenic properties. Protein Expr Purif. 1996 Sep;8(2):262–270. doi: 10.1006/prep.1996.0099. [DOI] [PubMed] [Google Scholar]
  19. McAtee C. P., Zhang Y., Yarbough P. O., Fuerst T. R., Stone K. L., Samander S., Williams K. R. Purification and characterization of a recombinant hepatitis E protein vaccine candidate by liquid chromatography-mass spectrometry. J Chromatogr B Biomed Appl. 1996 Oct 11;685(1):91–104. doi: 10.1016/0378-4347(96)00143-0. [DOI] [PubMed] [Google Scholar]
  20. Purdy M. A., McCaustland K. A., Krawczynski K., Spelbring J., Reyes G. R., Bradley D. W. Preliminary evidence that a trpE-HEV fusion protein protects cynomolgus macaques against challenge with wild-type hepatitis E virus (HEV). J Med Virol. 1993 Sep;41(1):90–94. doi: 10.1002/jmv.1890410118. [DOI] [PubMed] [Google Scholar]
  21. Reyes G. R., Huang C. C., Tam A. W., Purdy M. A. Molecular organization and replication of hepatitis E virus (HEV). Arch Virol Suppl. 1993;7:15–25. doi: 10.1007/978-3-7091-9300-6_2. [DOI] [PubMed] [Google Scholar]
  22. Reyes G. R., Purdy M. A., Kim J. P., Luk K. C., Young L. M., Fry K. E., Bradley D. W. Isolation of a cDNA from the virus responsible for enterically transmitted non-A, non-B hepatitis. Science. 1990 Mar 16;247(4948):1335–1339. doi: 10.1126/science.2107574. [DOI] [PubMed] [Google Scholar]
  23. Rozanov M. N., Koonin E. V., Gorbalenya A. E. Conservation of the putative methyltransferase domain: a hallmark of the 'Sindbis-like' supergroup of positive-strand RNA viruses. J Gen Virol. 1992 Aug;73(Pt 8):2129–2134. doi: 10.1099/0022-1317-73-8-2129. [DOI] [PubMed] [Google Scholar]
  24. Tam A. W., Smith M. M., Guerra M. E., Huang C. C., Bradley D. W., Fry K. E., Reyes G. R. Hepatitis E virus (HEV): molecular cloning and sequencing of the full-length viral genome. Virology. 1991 Nov;185(1):120–131. doi: 10.1016/0042-6822(91)90760-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Ticehurst J., Popkin T. J., Bryan J. P., Innis B. L., Duncan J. F., Ahmed A., Iqbal M., Malik I., Kapikian A. Z., Legters L. J. Association of hepatitis E virus with an outbreak of hepatitis in Pakistan: serologic responses and pattern of virus excretion. J Med Virol. 1992 Feb;36(2):84–92. doi: 10.1002/jmv.1890360205. [DOI] [PubMed] [Google Scholar]
  26. Ticehurst J., Rhodes L. L., Jr, Krawczynski K., Asher L. V., Engler W. F., Mensing T. L., Caudill J. D., Sjogren M. H., Hoke C. H., Jr, LeDuc J. W. Infection of owl monkeys (Aotus trivirgatus) and cynomolgus monkeys (Macaca fascicularis) with hepatitis E virus from Mexico. J Infect Dis. 1992 May;165(5):835–845. doi: 10.1093/infdis/165.5.835. [DOI] [PubMed] [Google Scholar]
  27. Tsarev S. A., Emerson S. U., Reyes G. R., Tsareva T. S., Legters L. J., Malik I. A., Iqbal M., Purcell R. H. Characterization of a prototype strain of hepatitis E virus. Proc Natl Acad Sci U S A. 1992 Jan 15;89(2):559–563. doi: 10.1073/pnas.89.2.559. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Tsarev S. A., Emerson S. U., Tsareva T. S., Yarbough P. O., Lewis M., Govindarajan S., Reyes G. R., Shapiro M., Purcell R. H. Variation in course of hepatitis E in experimentally infected cynomolgus monkeys. J Infect Dis. 1993 Jun;167(6):1302–1306. doi: 10.1093/infdis/167.6.1302. [DOI] [PubMed] [Google Scholar]
  29. Tsarev S. A., Tsareva T. S., Emerson S. U., Govindarajan S., Shapiro M., Gerin J. L., Purcell R. H. Successful passive and active immunization of cynomolgus monkeys against hepatitis E. Proc Natl Acad Sci U S A. 1994 Oct 11;91(21):10198–10202. doi: 10.1073/pnas.91.21.10198. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Tsarev S. A., Tsareva T. S., Emerson S. U., Kapikian A. Z., Ticehurst J., London W., Purcell R. H. ELISA for antibody to hepatitis E virus (HEV) based on complete open-reading frame-2 protein expressed in insect cells: identification of HEV infection in primates. J Infect Dis. 1993 Aug;168(2):369–378. doi: 10.1093/infdis/168.2.369. [DOI] [PubMed] [Google Scholar]
  31. Tsega E., Krawczynski K., Hansson B. G., Nordenfelt E. Hepatitis E virus infection in pregnancy in Ethiopia. Ethiop Med J. 1993 Jul;31(3):173–181. [PubMed] [Google Scholar]
  32. Yarbough P. O., Tam A. W., Fry K. E., Krawczynski K., McCaustland K. A., Bradley D. W., Reyes G. R. Hepatitis E virus: identification of type-common epitopes. J Virol. 1991 Nov;65(11):5790–5797. doi: 10.1128/jvi.65.11.5790-5797.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Zhang Y. F., Moss B. Inducer-dependent conditional-lethal mutant animal viruses. Proc Natl Acad Sci U S A. 1991 Feb 15;88(4):1511–1515. doi: 10.1073/pnas.88.4.1511. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Zhuang H., Cao X. Y., Liu C. B., Wang G. M. Epidemiology of hepatitis E in China. Gastroenterol Jpn. 1991 Jul;26 (Suppl 3):135–138. doi: 10.1007/BF02779283. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Diagnostic Laboratory Immunology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES